Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization.

Literature DB >> 11230455

Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization.

J W Dorigo-Zetsma¹, R P Verkooyen, H P van Helden, H van der Nat, J M van den Bosch.

Abstract

Mycoplasma pneumoniae infection was diagnosed in 18 (12.5%) of 144 adults hospitalized with community-acquired pneumonia. The infection was demonstrated by PCR in 15 patients and by serology, using two methods, in 10 patients. The mean age of the 8 patients with positive M. pneumoniae PCR and negative serology was significantly higher than that of the 10 patients with positive serology.

Entities: Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11230455 PMCID： PMC87901 DOI： 10.1128/JCM.39.3.1184-1186.2001

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

15 in total

Review 1. Bacterial infection in chronic obstructive pulmonary disease.

Authors: T F Murphy; S Sethi
Journal: Am Rev Respir Dis Date: 1992-10

2. Rapid and simple method for purification of nucleic acids.

Authors: R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal: J Clin Microbiol Date: 1990-03 Impact factor: 5.948

3. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital.

Authors: R Bohte; R van Furth; P J van den Broek
Journal: Thorax Date: 1995-05 Impact factor: 9.139

4. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence.

Authors: C E Barker; M Sillis; T G Wreghitt
Journal: J Clin Pathol Date: 1990-02 Impact factor: 3.411

5. Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients.

Authors: D Lieberman; F Schlaeffer; D Lieberman; S Horowitz; O Horovitz; A Porath
Journal: Respiration Date: 1996 Impact factor: 3.580

6. Microbial aetiology of community-acquired pneumonia in hospitalised patients.

Authors: M Socan; N Marinic-Fiser; A Kraigher; A Kotnik; M Logar
Journal: Eur J Clin Microbiol Infect Dis Date: 1999-11 Impact factor: 3.267

Review 7. The immune system in the elderly: I. Specific humoral immunity.

Authors: L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; M P Corsi; D Quaglino
Journal: Immunol Res Date: 1999 Impact factor: 2.829

8. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children.

Authors: J W Dorigo-Zetsma; S A Zaat; P M Wertheim-van Dillen; L Spanjaard; J Rijntjes; G van Waveren; J S Jensen; A F Angulo; J Dankert
Journal: J Clin Microbiol Date: 1999-01 Impact factor: 5.948

9. Community-acquired pneumonia requiring hospitalization: 5-year prospective study.

Authors: T J Marrie; H Durant; L Yates
Journal: Rev Infect Dis Date: 1989 Jul-Aug

10. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration.

Authors: A W Chow; C B Hall; J O Klein; R B Kammer; R D Meyer; J S Remington
Journal: Clin Infect Dis Date: 1992-11 Impact factor: 9.079

26 in total

Review 1. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors: K Loens; D Ursi; H Goossens; M Ieven
Journal: J Clin Microbiol Date: 2003-11 Impact factor: 5.948

2. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting.

Authors: Tim Schuurman; Richard F de Boer; Anna M D Kooistra-Smid; Anton A van Zwet
Journal: J Clin Microbiol Date: 2004-02 Impact factor: 5.948

3. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors: Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal: J Clin Microbiol Date: 2005-05 Impact factor: 5.948

4. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples.

Authors: Kristoffer Strålin; Eva Törnqvist; Margit Staum Kaltoft; Per Olcén; Hans Holmberg
Journal: J Clin Microbiol Date: 2006-02 Impact factor: 5.948

Review 5. Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors: K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal: J Clin Microbiol Date: 2008-11-19 Impact factor: 5.948

6. Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation.

Authors: Jonas M Winchell; Kathleen A Thurman; Stephanie L Mitchell; W Lanier Thacker; Barry S Fields
Journal: J Clin Microbiol Date: 2008-07-09 Impact factor: 5.948

Review 7. Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors: Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal: Clin Microbiol Rev Date: 2017-07 Impact factor: 26.132

8. Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study.

Authors: Alvaro J Benitez; Maureen H Diaz; Bernard J Wolff; Guillermo Pimentel; M Kariuki Njenga; Alejandra Estevez; Jonas M Winchell
Journal: J Clin Microbiol Date: 2012-09-05 Impact factor: 5.948

Review 9. Mycoplasma pneumoniae and its role as a human pathogen.

Authors: Ken B Waites; Deborah F Talkington
Journal: Clin Microbiol Rev Date: 2004-10 Impact factor: 26.132

10. Mycoplasma pneumonia: Clinical features and management.

Authors: Surender Kashyap; Malay Sarkar
Journal: Lung India Date: 2010-04